Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 286

1.

Treatment dilemmas in asymptomatic children with primary haemophagocytic lymphohistiocytosis.

Lucchini G, Marsh R, Gilmour K, Worth A, Nademi Z, Rao A, Booth C, Amrolia P, Silva J, Chiesa R, Wynn R, Lehmberg K, Astigarraga I, Gungor T, Stary J, Moshous D, Ifversen M, Zinn D, Jordan M, Kumar A, Yasumi T, Veys P, Rao K.

Blood. 2018 Aug 13. pii: blood-2018-01-827485. doi: 10.1182/blood-2018-01-827485. [Epub ahead of print]

PMID:
30104219
2.

Low incidence of symptomatic osteonecrosis after allogeneic HSCT in children with high-risk or relapsed ALL - results of the ALL-SCT 2003 trial.

Kuhlen M, Bader P, Sauer M, Albert MH, Gruhn B, Güngör T, Kropshofer G, Lang P, Lawitschka A, Metzler M, Pentek F, Rossig C, Schlegel PG, Schrappe M, Schrum J, Schulz A, Schwinger W, von Stackelberg A, Strahm B, Suttorp M, Luettichau IT, Wößmann W, Borkhardt A, Meisel R, Poetschger U, Glogova E, Peters C.

Br J Haematol. 2018 Jul 20. doi: 10.1111/bjh.15511. [Epub ahead of print]

PMID:
30028016
3.

Impact of lymph node ratio on survival in stage IIIC endometrioid endometrial cancer: a Turkish Gynecologic Oncology Group study.

Ayhan A, Topfedaisi Ozkan N, Öz M, Kimyon Comert G, Firat Cuylan Z, Çoban G, Turkmen O, Erdem B, Şahin H, Akbayır Ö, Dede M, Turan AT, Celik H, Güngör T, Haberal A, Arvas M, Meydanli MM.

J Gynecol Oncol. 2018 Jul;29(4):e48. doi: 10.3802/jgo.2018.29.e48. Epub 2018 Mar 13.

4.

Prognostic factors for maximally or optimally cytoreduced stage III nonserous epithelial ovarian carcinoma treated with carboplatin/paclitaxel chemotherapy.

Cuylan ZF, Meydanli MM, Sari ME, Akbayir O, Celik H, Dede M, Sahin H, Gungorduk K, Kuscu E, Ozgul N, Gungor T, Ayhan A.

J Obstet Gynaecol Res. 2018 Jul;44(7):1284-1293. doi: 10.1111/jog.13663. Epub 2018 May 4.

PMID:
29727055
5.

Is corona mortis a historical myth? A perspective from a gynecologic oncologist

Selçuk İ, Tatar İ, Fırat A, Huri E, Güngör T.

J Turk Ger Gynecol Assoc. 2018 Aug 6;19(3):171-172. doi: 10.4274/jtgga.2018.0017. Epub 2018 Apr 27. No abstract available.

6.

Allogeneic hematopoietic cell transplantation in Farber disease.

Ehlert K, Levade T, Di Rocco M, Lanino E, Albert MH, Führer M, Jarisch A, Güngör T, Ayuk F, Vormoor J.

J Inherit Metab Dis. 2018 Mar 29. doi: 10.1007/s10545-018-0171-6. [Epub ahead of print]

PMID:
29600496
7.

Prognostic factors and patterns of recurrence in lymphovascular space invasion positive women with stage IIIC endometriod endometrial cancer.

Cuylan ZF, Oz M, Ozkan NT, Comert GK, Sahin H, Turan T, Akbayir O, Kuscu E, Celik H, Dede M, Gungor T, Meydanli MM, Ayhan A.

J Obstet Gynaecol Res. 2018 Jun;44(6):1140-1149. doi: 10.1111/jog.13615. Epub 2018 Mar 8.

PMID:
29516573
8.

Does the primary route of spread have a prognostic significance in stage III non-serous epithelial ovarian cancer?

Sahin H, Meydanli MM, Sari ME, Yalcin I, Çoban G, Ozkan NT, Cuylan ZF, Erdem B, Gungorduk K, Akbayir Ö, Dede M, Salman MC, Güngör T, Ayhan A.

J Ovarian Res. 2018 Mar 5;11(1):21. doi: 10.1186/s13048-018-0393-0.

9.

Haematopoietic cell transplantation in Switzerland, changes and results over 20 years: a report from the Swiss Blood Stem Cell Transplantation Working Group for Blood and Marrow Transplantation registry 1997-2016.

Passweg JR, Baldomero H, Ansari M, Baerlocher GM, Bargetzi M, Chalandon Y, Duchosal MA, Gerull S, Güngör T, Halter JP, Heim D, Hess U, Leibundgut K, Masouridi-Levrat S, Müller A, Nair G, Pabst T, Renner C, Schmidt A, Stussi G, Nicoloso de Faveri G, Schanz U, For The Swiss Blood Stem Cell Transplantation Group Sbst.

Swiss Med Wkly. 2018 Mar 1;148:w14589. doi: 10.4414/smw.2018.14589. eCollection 2018.

10.

Canakinumab treatment in children with familial Mediterranean fever: report from a single center.

Yazılıtaş F, Aydoğ Ö, Özlü SG, Çakıcı EK, Güngör T, Eroğlu FK, Gür G, Bülbül M.

Rheumatol Int. 2018 May;38(5):879-885. doi: 10.1007/s00296-018-3993-5. Epub 2018 Feb 15.

PMID:
29450637
11.

Is the presence of endometriosis associated with a survival benefit in pure ovarian clear cell carcinoma?

Sahin H, Sari ME, Cuylan ZF, Haberal AN, Sirvan L, Coban G, Yalcin I, Güngör T, Celik H, Meydanli MM, Ayhan A.

Arch Gynecol Obstet. 2018 Apr;297(4):1005-1013. doi: 10.1007/s00404-018-4651-6. Epub 2018 Jan 30.

PMID:
29383437
12.

Publisher Correction: Evaluation of the level of dynamic thiol/disulphide homeostasis in adolescent patients with newly diagnosed primary hypertension.

Çakıcı EK, Eroğlu FK, Yazılıtaş F, Bülbül M, Gür G, Aydoğ Ö, Güngör T, Erel Ö, Alışık M, Elhan AH.

Pediatr Nephrol. 2018 Jun;33(6):1099. doi: 10.1007/s00467-018-3896-4.

PMID:
29380070
13.

Persistent mammalian orthoreovirus, coxsackievirus and adenovirus co-infection in a child with a primary immunodeficiency detected by metagenomic sequencing: a case report.

Lewandowska DW, Capaul R, Prader S, Zagordi O, Geissberger FD, Kügler M, Knorr M, Berger C, Güngör T, Reichenbach J, Shah C, Böni J, Zbinden A, Trkola A, Pachlopnik Schmid J, Huber M.

BMC Infect Dis. 2018 Jan 11;18(1):33. doi: 10.1186/s12879-018-2946-7.

14.

Vanishing endometrial carcinoma in hysterectomy specimens: probable implications for fertility sparing management

Öz M, Karalök A, Şirvan L, Taşçı T, Öcalan R, Turan AT, Güngör T, Meydanlı MM.

Turk J Med Sci. 2017 Dec 19;47(6):1744-1750. doi: 10.3906/sag-1607-93.

PMID:
29306233
15.

Evaluation of the level of dynamic thiol/disulphide homeostasis in adolescent patients with newly diagnosed primary hypertension.

Çakıcı EK, Eroğlu FK, Yazılıtaş F, Bülbül M, Gür G, Aydoğ Ö, Güngör T, Erel Ö, Alışık M, Elhan AH.

Pediatr Nephrol. 2018 May;33(5):847-853. doi: 10.1007/s00467-017-3865-3. Epub 2018 Jan 2. Erratum in: Pediatr Nephrol. 2018 Jan 29;:.

PMID:
29297098
16.

Worldwide study of hematopoietic allogeneic stem cell transplantation in pyruvate kinase deficiency.

van Straaten S, Bierings M, Bianchi P, Akiyoshi K, Kanno H, Serra IB, Chen J, Huang X, van Beers E, Ekwattanakit S, Güngör T, Kors WA, Smiers F, Raymakers R, Yanez L, Sevilla J, van Solinge W, Segovia JC, van Wijk R.

Haematologica. 2018 Feb;103(2):e82-e86. doi: 10.3324/haematol.2017.177857. Epub 2017 Dec 14. No abstract available.

17.

Prodrugs for Nitroreductase Based Cancer Therapy- 1: Metabolite Profile, Cell Cytotoxicity and Molecular Modeling Interactions of Nitro Benzamides with Ssap-NtrB.

Gungor T, Yetis G, Onder FC, Tokay E, Tok TT, Celik A, Ay M, Kockar F.

Med Chem. 2018;14(5):495-507. doi: 10.2174/1573406413666171129224424.

PMID:
29189173
18.

Impact of lymph node ratio on survival in stage III ovarian high-grade serous cancer: a Turkish Gynecologic Oncology Group study.

Ayhan A, Ozkan NT, Sarı ME, Celik H, Dede M, Akbayır Ö, Güngördük K, Şahin H, Haberal A, Güngör T, Arvas M, Meydanlı MM.

J Gynecol Oncol. 2018 Jan;29(1):e12. doi: 10.3802/jgo.2018.29.e12.

19.

Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment.

Yalcin I, Meydanli MM, Turan AT, Taskin S, Sari ME, Gungor T, Akbayir O, Ayhan A.

Int J Clin Oncol. 2018 Apr;23(2):329-337. doi: 10.1007/s10147-017-1215-x. Epub 2017 Nov 16.

PMID:
29143144
20.

Comparison of three different risk-stratification models for predicting lymph node involvement in endometrioid endometrial cancer clinically confined to the uterus.

Korkmaz V, Meydanli MM, Yalçın I, Sarı ME, Sahin H, Kocaman E, Haberal A, Dursun P, Güngör T, Ayhan A.

J Gynecol Oncol. 2017 Nov;28(6):e78. doi: 10.3802/jgo.2017.28.e78.

21.

The Impact of Surgical Staging on the Prognosis of Mucinous Borderline Tumors of the Ovaries: A Multicenter Study.

Gungorduk K, Asicioglu O, Braicu EI, Almuheimid J, Gokulu SG, Cetinkaya N, Gungor T, Pakay G, Telli EU, Cuylan ZF, Toptas T, Bilgi A, Ozyurt R, Agacayak E, Ozdemir A, Yildirim N, Taskin S, Oge T, Erol O, Akman L, Turan A, Icen MS, Senol T, Ovali OI, Yucesoy B, Gungorduk O, Temizkan O, Sanci M, Simsek T, Meydanli MM, Harma M, Yasar L, Uysal AD, Karateke A, Ortac F, Ozalp SS, Sehouli J, Muallem MZ.

Anticancer Res. 2017 Oct;37(10):5609-5616.

PMID:
28982877
22.

Oncological Outcomes of Stage II Endometrial Cancer: A Retrospective Analysis of 250 Cases.

Ozgul N, Boyraz G, Salman MC, Gultekin M, Yuce K, Ibrahimov A, Erturk A, Gungorduk K, Gulseren V, Sanci M, Turkmen O, Karalok A, Kimyon G, Turan T, Ozkan NT, Meydanli MM, Gungor T, Ayik H, Simsek T.

Int J Gynecol Cancer. 2018 Jan;28(1):161-167. doi: 10.1097/IGC.0000000000001133.

PMID:
28930810
23.

Discovery and genotyping of novel sequence insertions in many sequenced individuals.

Kavak P, Lin YY, Numanagic I, Asghari H, Güngör T, Alkan C, Hach F.

Bioinformatics. 2017 Jul 15;33(14):i161-i169. doi: 10.1093/bioinformatics/btx254.

24.

What is the impact of stromal microinvasion on oncologic outcomes in borderline ovarian tumors? A multicenter case-control study.

Boyraz G, Salman MC, Gultekin M, Ozkan NT, Uckan HH, Gungorduk K, Gulseren V, Ayik H, Toptas T, Kuru O, Sozen H, Erturk A, Ozgul N, Meydanlı MM, Sanci M, Turan T, Gungor T, Simsek T, Topuz S, Yuce K.

Arch Gynecol Obstet. 2017 Nov;296(5):979-987. doi: 10.1007/s00404-017-4496-4. Epub 2017 Sep 2.

PMID:
28866783
25.

Erratum to: The role of thrombocytosis in prognostic evaluation of epithelial ovarian tumors.

Gungor T, Kanat-Pektas M, Sucak A, Mollamahmutoglu L.

Arch Gynecol Obstet. 2017 Oct;296(4):847. doi: 10.1007/s00404-017-4483-9. No abstract available.

PMID:
28821919
26.

Unusual retinopathy in a child with severe combined immune deficiency.

Gerth-Kahlert C, Tiwari A, Hauri-Hohl MM, Hanson JVM, Bahr A, Palmowski-Wolfe A, Güngör T, Berger W.

Ophthalmic Genet. 2018 Jan-Feb;39(1):92-94. doi: 10.1080/13816810.2017.1350721. Epub 2017 Aug 16.

PMID:
28812413
27.

The outcomes of intestinal resection during debulking surgery for ovarian cancer.

Terzioğlu SG, Kılıç MÖ, Çetinkaya N, Baser E, Güngör T, Adıgüzel C.

Turk J Surg. 2017 Jun 1;33(2):96-99. doi: 10.5152/UCD.2016.3515. eCollection 2017.

28.

Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

Miot C, Imai K, Imai C, Mancini AJ, Kucuk ZY, Kawai T, Nishikomori R, Ito E, Pellier I, Dupuis Girod S, Rosain J, Sasaki S, Chandrakasan S, Pachlopnik Schmid J, Okano T, Colin E, Olaya-Vargas A, Yamazaki-Nakashimada M, Qasim W, Espinosa Padilla S, Jones A, Krol A, Cole N, Jolles S, Bleesing J, Vraetz T, Gennery AR, Abinun M, Güngör T, Costa-Carvalho B, Condino-Neto A, Veys P, Holland SM, Uzel G, Moshous D, Neven B, Blanche S, Ehl S, Döffinger R, Patel SY, Puel A, Bustamante J, Gelfand EW, Casanova JL, Orange JS, Picard C.

Blood. 2017 Sep 21;130(12):1456-1467. doi: 10.1182/blood-2017-03-771600. Epub 2017 Jul 5.

PMID:
28679735
29.

Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone.

Topfedaisi Ozkan N, Meydanlı MM, Sarı ME, Demirkiran F, Kahramanoglu I, Bese T, Arvas M, Şahin H, Haberal A, Celik H, Coban G, Oge T, Yalcin OT, Akbayır Ö, Erdem B, Numanoğlu C, Özgül N, Boyraz G, Salman MC, Yüce K, Dede M, Yenen MC, Taşkın S, Altın D, Ortaç UF, Aydın Ayık H, Şimşek T, Güngör T, Güngördük K, Sancı M, Ayhan A.

J Gynecol Oncol. 2017 Sep;28(5):e65. doi: 10.3802/jgo.2017.28.e65. Epub 2017 Jun 16.

30.

Is Tumor Size Really Important for Prediction of Lymphatic Dissemination in Grade 1 Endometrial Carcinoma With Superficial Myometrial Invasion?

Oz M, Korkmaz V, Meydanli MM, Sari ME, Cuylan ZF, Gungor T.

Int J Gynecol Cancer. 2017 Sep;27(7):1393-1398. doi: 10.1097/IGC.0000000000001025.

PMID:
28604451
31.

Prognostic factors and treatment outcomes in surgically-staged non-invasive uterine clear cell carcinoma: a Turkish Gynecologic Oncology Group study.

Sarı ME, Meydanlı MM, Türkmen O, Cömert GK, Turan AT, Karalök A, Şahin H, Haberal A, Kocaman E, Akbayır Ö, Erdem B, Numanoğlu C, Güngördük K, Sancı M, Gökçü M, Özgül N, Salman MC, Boyraz G, Yüce K, Güngör T, Taşkın S, Altın D, Ortaç UF, Ayık HA, Şimşek T, Arvas M, Ayhan A.

J Gynecol Oncol. 2017 Jul;28(4):e49. doi: 10.3802/jgo.2017.28.e49.

32.

Risk factors for paraaortic lymph node metastasis in endometrial cancer.

Sari ME, Yalcin İ, Sahin H, Meydanli MM, Gungor T.

Int J Clin Oncol. 2017 Oct;22(5):937-944. doi: 10.1007/s10147-017-1139-5. Epub 2017 May 18.

PMID:
28523533
33.

Comparison of bilateral transversus abdominis plane block and wound infiltration with bupivacaine for postoperative analgesia after cesarean delivery.

Görkem Ü, Koçyiğit K, Toğrul C, Güngör T.

J Turk Ger Gynecol Assoc. 2017 Mar 15;18(1):26-32. doi: 10.4274/jtgga.2016.0155.

34.

Risk factors for appendiceal involvement in women with epithelial ovarian cancer.

Sarı ME, Korkmaz E, Öz M, Güngör T, Meydanlı MM.

J Turk Ger Gynecol Assoc. 2017 Sep 1;18(3):116-121. doi: 10.4274/jtgga.2017.0005. Epub 2017 May 11.

35.

A rare case of leiomyosarcoma originating from the left round ligament of the uterus.

Kaba M, Tokmak A, Timur H, Özdal B, Şirvan L, Güngör T.

J Exp Ther Oncol. 2016 Jul;11(3):237-240.

PMID:
28471132
36.

Could 25-OH vitamin D deficiency be a reason for HPV infection persistence in cervical premalignant lesions?

Özgü E, Yılmaz N, Başer E, Güngör T, Erkaya S, Yakut Hİ.

J Exp Ther Oncol. 2016 Jul;11(3):177-180.

PMID:
28471122
37.

Anti-Müllerian hormone exhibits a great variation in infertile women with different ovarian reserve patterns.

Gorkem U, Kucukler FK, Togrul C, Gungor T.

Aust N Z J Obstet Gynaecol. 2017 Aug;57(4):464-468. doi: 10.1111/ajo.12625. Epub 2017 Apr 17.

PMID:
28419409
38.

Outcome of hematopoietic cell transplantation for DNA double-strand break repair disorders.

Slack J, Albert MH, Balashov D, Belohradsky BH, Bertaina A, Bleesing J, Booth C, Buechner J, Buckley RH, Ouachée-Chardin M, Deripapa E, Drabko K, Eapen M, Feuchtinger T, Finocchi A, Gaspar HB, Ghosh S, Gillio A, Gonzalez-Granado LI, Grunebaum E, Güngör T, Heilmann C, Helminen M, Higuchi K, Imai K, Kalwak K, Kanazawa N, Karasu G, Kucuk ZY, Laberko A, Lange A, Mahlaoui N, Meisel R, Moshous D, Muramatsu H, Parikh S, Pasic S, Schmid I, Schuetz C, Schulz A, Schultz KR, Shaw PJ, Slatter MA, Sykora KW, Tamura S, Taskinen M, Wawer A, Wolska-Kuśnierz B, Cowan MJ, Fischer A, Gennery AR; Inborn Errors Working Party of the European Society for Blood and Marrow Transplantation and the European Society for Immunodeficiencies; Stem Cell Transplant for Immunodeficiencies in Europe (SCETIDE); Center for International Blood and Marrow Transplant Research; Primary Immunodeficiency Treatment Consortium.

J Allergy Clin Immunol. 2018 Jan;141(1):322-328.e10. doi: 10.1016/j.jaci.2017.02.036. Epub 2017 Apr 7.

PMID:
28392333
39.

A New Diagnostic and Prognostic Marker in Endometrial Cancer: Neopterin.

Isci Bostanci E, Ugras Dikmen A, Girgin G, Gungor T, Baydar T, Nuri Danisman A.

Int J Gynecol Cancer. 2017 May;27(4):754-758. doi: 10.1097/IGC.0000000000000952.

PMID:
28383326
40.

Comparison Of Early-Stage High-Grade Serous Primary Fallopian Tube Cancers and Epithelial Ovarian Cancers: A Multicenter Study.

Gungorduk K, Ozdemir A, Selcuk I, Telli E, Şahin Ö, Toptaş T, Akman L, Güzel AB, Taşkın S, Öge T, Güngördük Ö, Gokçü M, Gungor T, Yaşar L, Terek MC, Ozan H, Ozsaran A, Sancı M, Vardar MA, Meydanlı MM, Yalçın ÖT, Ortac F, Özalp S.

Oncol Res Treat. 2017;40(4):203-206. doi: 10.1159/000458440. Epub 2017 Mar 21.

41.

Causes of low neonatal T-cell receptor excision circles: A systematic review.

Mauracher AA, Pagliarulo F, Faes L, Vavassori S, Güngör T, Bachmann LM, Pachlopnik Schmid J.

J Allergy Clin Immunol Pract. 2017 Sep - Oct;5(5):1457-1460.e22. doi: 10.1016/j.jaip.2017.02.009. Epub 2017 Mar 27. No abstract available.

PMID:
28359806
42.

Iatrogenic implantation of placental tissue after first trimester dilatation and curettage presenting as a uterine mass: A report of two cases.

Topfedaisi Özkan N, Erkan Sarı M, Görkem Ü, Bayramoğlu H, Akbay S, Mutlu Meydanlı M, Güngör T.

J Obstet Gynaecol. 2017 Aug;37(6):801-803. doi: 10.1080/01443615.2017.1286301. Epub 2017 Mar 21. No abstract available.

PMID:
28325128
43.

The effects of umbilical cord entanglement upon labor management and fetal health: retrospective case control study.

Buyukkayaci Duman N, Topuz S, Bostanci MO, Gorkem U, Yuksel Kocak D, Togrul C, Gungor T.

J Matern Fetal Neonatal Med. 2018 Mar;31(5):656-660. doi: 10.1080/14767058.2017.1293033. Epub 2017 Feb 28.

PMID:
28282778
44.

Is lower uterine segment involvement a prognostic factor in endometrial cancer?

Erkaya S, Öz M, Topçu HO, Şirvan AL, Güngör T, Meydanli MM.

Turk J Med Sci. 2017 Feb 27;47(1):300-306. doi: 10.3906/sag-1602-137.

PMID:
28263506
45.

Are adipokines associated with gestational diabetes mellitus?

Görkem Ü, Küçükler FK, Toğrul C, Güngör T.

J Turk Ger Gynecol Assoc. 2016 Dec 1;17(4):186-190. eCollection 2016.

46.

Biological evaluation and molecular docking studies of nitro benzamide derivatives with respect to in vitro anti-inflammatory activity.

Tumer TB, Onder FC, Ipek H, Gungor T, Savranoglu S, Tok TT, Celik A, Ay M.

Int Immunopharmacol. 2017 Feb;43:129-139. doi: 10.1016/j.intimp.2016.12.009. Epub 2016 Dec 16.

PMID:
27988460
47.

Uterine adenosarcomas: A dual-institution experience.

Özgü E, Narin MA, Yalçın HR, Taşçı T, Güngör T, Çavuşoğlu D, Meydanlı MM, Tulunay G.

J Obstet Gynaecol. 2017 Jan;37(1):93-96. doi: 10.1080/01443615.2016.1228619. Epub 2016 Dec 6.

PMID:
27923317
48.

Borderline ovarian tumors: clinical characteristics, management, and outcomes - a multicenter study.

Gokcu M, Gungorduk K, Aşıcıoğlu O, Çetinkaya N, Güngör T, Pakay G, Cüylan ZF, Toptaş T, Özyurt R, Ağaçayak E, Ozdemir A, Erol O, Turan A, Gülseren V, İcen MS, Şenol T, Güraslan H, Yücesoy B, Sahbaz A, Gungorduk O, Besimoğlu B, Pakay K, Temizkan O, Sancı M, Şimşek T, Meydanlı MM, Harma M, Yaşar L, Boran B, Uysal AD, Karateke A.

J Ovarian Res. 2016 Oct 18;9(1):66.

49.

Extrauterine Spread, Adjuvant Treatment, and Prognosis in Noninvasive Uterine Papillary Serous Carcinoma of the Endometrium: A Retrospective Multicenter Study.

Boyraz G, Salman MC, Basaran D, Ozgul N, Turan T, Turkmen O, Kimyon GC, Ozkan NT, Cagan M, Gungor T, Meydanli MM, Gungorduk K, Gulseren V, Sanci M, Yuce K.

Int J Gynecol Cancer. 2017 Jan;27(1):102-108. doi: 10.1097/IGC.0000000000000838.

PMID:
27668395
50.

Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.

Bartelink IH, Lalmohamed A, van Reij EM, Dvorak CC, Savic RM, Zwaveling J, Bredius RG, Egberts AC, Bierings M, Kletzel M, Shaw PJ, Nath CE, Hempel G, Ansari M, Krajinovic M, Théorêt Y, Duval M, Keizer RJ, Bittencourt H, Hassan M, Güngör T, Wynn RF, Veys P, Cuvelier GD, Marktel S, Chiesa R, Cowan MJ, Slatter MA, Stricherz MK, Jennissen C, Long-Boyle JR, Boelens JJ.

Lancet Haematol. 2016 Nov;3(11):e526-e536. doi: 10.1016/S2352-3026(16)30114-4. Epub 2016 Oct 13.

Supplemental Content

Loading ...
Support Center